Neuroendocrine Tumor G1 — Trials

Neuroendocrine Tumor G1 — Trials · CancerIndex

Clinical trials

Registered studies

65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00227617	Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors	terminated	Phase 2 / Phase 3	36	University of California, San FranciscoOTHER	1	May 22, 2023	clinicaltrials
NCT00903396	Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer	terminated	Phase 2	7	Alliance for Clinical Trials in OncologyOTHER	1	Nov 24, 2017